Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
[18F]FP-R01-MG-F2 PET in Pancreatic Cancer
NCT02683824Phase 1Completed
- Sponsor
- Stanford University
- Start
- Jan 2016
- Primary completion
- Sep 2021
- Countries
- 1
01
Overview
Phase 1, open-label trial (2 arms), sponsored by Stanford University. Primary endpoints: Biodistribution of [18F]FP-R01-MG-F2 (%ID/g) at 3 hours, Biodistribution of [18F]FP-R01-MG-F2 (SUV) at 3 hours and 2 more. Started Jan 2016; status: completed.
Beyond the preview
Go deeper on NCT02683824.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02683824.